Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Motor imagery–enhanced rehab after ACL reconstruction

Official title: Motor Imagery-Enhanced Rehabilitation Modulates Cortical Plasticity and Functional Recovery After ACL Reconstruction

Run by Peking University Third Hospital · NCT07833189 · Data updated 2026-11-12

This study tests whether mentally practicing movement can improve knee function and brain activity after ACL reconstruction, in comparison with standard rehab.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment80 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJune 15, 2026
Main results expectedAugust 10, 2027
Study endsAugust 10, 2027
Registry record updatedSeptember 22, 2026
Trial IDNCT07833189 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-45 who are 12 months post single-bundle hamstring autograft ACL reconstruction with stable knee and no major comorbidities.

Probably not a fit

Individuals outside the 18-45 age range or with additional knee injuries, long-delayed surgery, or prior knee surgeries may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project has two parts. Part 1 compares EEG patterns and functional performance during tasks and motor imagery between people 12 months after ACL reconstruction and healthy controls to identify neural and behavioral differences. Part 2 is a 12-week randomized controlled trial where ACL rupture patients receive either motor imagery therapy or conventional rehabilitation, with EEG, kinematic, and imaging data collected to explore neuroplastic changes in sensorimotor networks. The aim is to see if the central-driven peripheral approach can enhance recovery and brain–body coordination after ACL surgery.

Why it matters

Potential benefit: If successful, patients may achieve better knee function and faster return to sport through a brain-informed rehabilitation approach.

How similar studies have gone: Prior work suggests motor imagery can influence motor function and brain activity, but this specific combined EEG/fMRI and rehabilitation approach is novel in ACL recovery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Part 1: Participants

Study Design:

* This study will recruit 20 patients at 12 months after ACL reconstruction and 20 healthy controls.
* Age range: 18-45 years.

Inclusion Criteria for Patient Group:

* Age: 18-45 years old.
* Body Mass Index (BMI): ≥18.5 kg/m² and \<35 kg/m².
* Injury Type: First-time unilateral isolated ACL rupture, reconstructed at our hospital.
* Surgical Technique: Single-bundle hamstring tendon autograft transplantation.
* Ligament Stability: No injury or only mild injury (Grade I) to the PCL, MCL, or LCL.
* Postoperative Timeline: 12 months after ACL reconstruction.
* Consent: Voluntary participation with signed informed consent.

Exclusion Criteria for Patient Group:

* Delayed Surgery: ACL reconstruction performed \>6 months after injury.
* Combined Injuries: Severe injury (\>Grade I) to PCL, MCL, or LCL; severe meniscus tear.
* Previous Surgery: History of lower limb knee surgery (e.g., meniscus repair, arthroplasty).
* Comorbidities: Existing knee diseases (e.g., osteoarthritis, tumors, rheumatoid arthritis, fracture).
* Systemic/Cognitive Issues: Severe cardiac, pulmonary, cerebral disease, or hepatic/renal dysfunction; visual or cognitive impairment.
* Imagery Ability: Score \<55 on the KVIQ-20.

Inclusion Criteria for Healthy Controls:

* Age: 18-45 years old.
* Body Mass Index (BMI): ≥18.5 kg/m² and \<35 kg/m².
* Medical History: No history of surgery, injury, or chronic lower limb joint disease.
* Neurological Status: No visual/cognitive impairment or neurological disorders.
* Gait: No trauma or disease causing gait abnormalities.
* Consent: Voluntary participation with signed informed consent.
* Imagery Ability: Score \<55 on the KVIQ-20. Study 2: Participants

Study Design:

* This study aims to recruit 40 patients meeting the specified criteria.
* Randomization: Participants will be randomly allocated into an experimental group (N=20) and a control group (N=20).

Inclusion Criteria for Patients:

* Age: 18-45 years old.
* Body Mass Index (BMI): ≥18.5 kg/m² and \<35 kg/m².
* Injury Type: First-time unilateral isolated ACL rupture, reconstructed at our hospital.
* Surgical Technique: Single-bundle hamstring tendon autograft transplantation.
* Ligament Stability: No injury or only mild injury (Grade I) to the PCL, MCL, or LCL.
* Consent: Voluntary participation with signed informed consent.
* Exclusion Criteria for Patients:
* Delayed Surgery: ACL reconstruction performed \>6 months after injury.
* Combined Injuries: Severe injury (\>Grade I) to PCL, MCL, or LCL (Grade II-III); severe meniscus tear.
* Previous Surgery: History of lower limb knee surgery (e.g., meniscus repair, ligament reconstruction, arthroplasty).
* Comorbidities: Existing knee diseases (e.g., osteoarthritis, tumors, rheumatoid arthritis, tuberculosis, infection).
* Systemic/Cognitive Issues: Severe cardiac, pulmonary, cerebral disease, or hepatic/renal dysfunction; visual or cognitive impairment.
* Imagery Ability: Score \<55 on the KVIQ-20.

Where it's running

  • Peking University Third Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.